J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fowler, A.
Right arrow Articles by Mackay, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fowler, A.
Right arrow Articles by Mackay, A.
Agricola
Right arrow Articles by Fowler, A.
Right arrow Articles by Mackay, A.
J Med Microbiol 55 (2006), 123-125; DOI: 10.1099/jmm.0.46271-0
© 2006 Society for General Microbiology
ISSN 0022-2615


Case Report

Community-acquired methicillin-resistant Staphylococcus aureus pyomyositis in an intravenous drug user

A. Fowler and A. Mackay

Department of Microbiology, Queen Elizabeth Hospital, Woolwich, London SE18 4QH, UK

Correspondence
A. Fowler
afowler{at}doctors.org.uk

Received 1 August 2005
Accepted 5 September 2005


Pyomyositis is a disease of abscess formation deep within large striated muscles. Outside of the tropics it is a rare disease which occurs mainly in certain patient populations such as the immunosuppressed or intravenous drug users (IDUs). A case of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) pyomyositis in an IDU is described. The incidence of both CA-MRSA and pyomyositis is currently increasing. To the authors' knowledge this is the first reported case of CA-MRSA pyomyositis in the UK. Cases of CA-MRSA pyomyositis are likely to increase and it may be necessary to empirically treat certain patients with glycopeptides.


Abbreviations: CA-MRSA, community-acquired methicillin-resistant Staphylococcus aureus; DVT, deep vein thrombosis; ICU, intensive care unit; IDU, intravenous drug user.




This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
N. F. Crum-Cianflone
Bacterial, Fungal, Parasitic, and Viral Myositis
Clin. Microbiol. Rev., July 1, 2008; 21(3): 473 - 494.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2006 Society for General Microbiology.